CLINICAL ROLE -
Crohnâ€™s Disease Treatments Alter Components of Gut Microbiome
Granix by Teva Pharmaceuticals, Inc
Granix is a human granulocyte factor produced in a bioreactor using recombinant DNA technology.
Stem Cell Transplant Shows No Improvement in Crohnâ€™s Disease
Certain Fatty Acids Responsible for Worsening Crohnâ€™s Disease
Role of Specialty Pharmacists in Preventing Vision Loss Resulting from Macular Edema
A Look into Hepatitis C Treatment Options from a Clinical and Managed Care Perspective
Challenges Continue for True Patient-Centered Access
Access to oral chemotherapies is filled with challenges for providers and patients that can be significant, resulting in delayed therapy.
Understanding Closed-System Transfer Devices: Why They Are Important and How to Select an Appropriate System
CSTDs can help protect health care workers, including pharmacists and nurses, from hazardous chemotherapy drugs.
Powering Decision Support for Specialty Drugs: How Technology is Keeping Pace with Therapeutic Breakthroughs in Hepatitis C and Oncology
Physicians are challenged with differentiating among a wide array of treatment options, with varying regimens and indications, and then monitoring patients according to the specific guidelines for each therapy.
Cancer: The Next Frontier in Chronic Care Management
As with care for any chronic condition, the goals for advanced oncology therapies should be improving outcomes, containing costs, and increasing medication adherence.
Not Just a Generic: Specialty Pharmacy Considerations for a Biosimilar Launch
As new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.
Patient Satisfaction: The Real Barometer for Success in Specialty
Misinformation among consumers and the media regarding specialty pharmacies illustrates the importance of leveraging factual information to highlight specialty services for patients to raise the customer service bar even higher.
Adherence to Oral Oncolytics Requires a Clinically Integrated Approach to Specialty Pharmacy
Despite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.
Three Current Policy Discussions Influencing Cancer Drug Development
Despite progress in reducing cancer mortality, more work is needed to improve patient outcomes in this disease state.
Specialty Drug Copay Coupons: Despite Patient Benefits, Compliance Issues Persist
Conflicting opinions surround drug copay coupons, which can improve out-of-pocket costs while decreasing the effectiveness of cost-sharing requirements that promote prudent prescribing and purchasing choices.
Overcoming Challenges to Progress in Oncology
2 Clarke Drive Cranbury, NJ 08512